Our Mission

Human-Like Tissue

Utilizing a passionate and talented team, VoxCell is providing an extraordinary line of human-like tissue solutions for the drug development industry and the field of Oncology research by creating 3D vascularized cancer tissue models. Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D bioprinted tissues. Combined with our proprietary software, we are able to print tissues with vasculature for more meaningful in vitro testing. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bioprinters.

Our tissue models will increase confidence in new drug candidates, decrease the failure rate (currently more than 95% of drugs in the pipeline fail), and impact the speed for new therapies to get to market. The successful translation between pre-clinical trial data and clinical trial results is less than 8% and we are on a mission to change that.

 

Testing on human-like tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life saving therapies to market and in the hands of people who need them sooner.

Meet The Team

Karol Small_edited.png
Untitled design (3)_edited.png

Karolina Valente, Ph.D.

CEO & CSO

Sebastian_edited.png
Untitled design (3)_edited.png

Sebastian Steiner, Ph.D.

Head of Engineering

Charlotte Ellis.png
Untitled design (3)_edited.png

Charlotte Ellis, Ph.D.

Senior Chemist

Megan Chisling.png
Untitled design (3)_edited.png

Megan Chisling

Junior Biophotonics Engineer

dsc09517jpg_51991581059_o-removebg-preview_edited.png
Untitled design (3)_edited.png

Asees Kaur

Junior Mechanical Engineer

Dan Wattier_edited.png
Untitled design (3)_edited.png

Dan Wattier

CBO

Austyn Roelofs_edited.png
Untitled design (3)_edited.png

Austyn Roelofs

Tissue Engineer

Byron Kontou_edited.png
Untitled design (3)_edited.png

Byron Kontou

Software Developer

Headshot_edited.png
Untitled design (3)_edited.png

Evan Stefanek

Mechanical Engineer

shael_headshot_edited._edited.png
Untitled design (3)_edited.png

Shael Mazzone

Office Manager

Kevin Vos.png
Untitled design (3)_edited.png

Kevin Vos, Ph.D.

Director of Preclinical R&D

Cameron Polglase_edited.png
Untitled design (3)_edited.png

Cameron Polglase

Biophotonics Engineer

Benjamin Rampado.png
Untitled design (3)_edited.png

Benjamin Rampado

Chemist

Ian DeJong.png
Untitled design (3)_edited.png

Ian DeJong

Junior Software Developer

CO-OP Students

Annelise_edited_edited.png
Untitled design (3)_edited.png

Annelise Lapointe

Research and Development Engineering

ADvisors and partners

Alexandre Brolo.png
Untitled design (3)_edited.png

Alexandre Brolo, Ph.D.

Partner

Alvin Chubbs.png
Untitled design (3)_edited.png

Alvin Chubbs

Advisor - Business & Finance

Nathan Lindquist.png
Untitled design (3)_edited.png

Nathan Lindquist, Ph.D.

Advisor - Optics.

Madhu Singh.png
Untitled design (3)_edited.png

Madhu Singh, Ph.D.

Advisor - Oncology

Dave Leitch.png
Untitled design (3)_edited.png

Dave Leitch, Ph.D.

Advisor - Pharma

Georgina Rizik_edited.png
Untitled design (3)_edited.png

Georgina Rizik, MBA.

Advisor - Strategy

Board Members

Karol Small_edited.png
Untitled design (3)_edited.png

Karolina Valente, Ph.D.

CEO & CSO, Board

Nina Vellani.png
Untitled design (3)_edited.png

Nina Vellani, Ph.D.

Board

Robert Levak.png
Untitled design (3)_edited.png

Robert Levak

Board